IFNA1 and neoplasm: These treatments, especially antilymphocyte serum, cyclosporine, and IFN, could alter the integrity of the ATL cell, inducing apoptosis or repressing tumor extension through their anti-inflammatory effects and thus contributing to a slow evolutionary process [32].